Schizophrenia and Schizoaffective Disorders

Schizophrenia and schizoaffective disorders are severe mental conditions characterized by hallucinations, delusions, and mood disturbances. The Journal of Clinical Psychiatry offers a deep dive into these disorders, emphasizing their diagnosis, management, and underlying causes. Our expert editors ensure content is both clinically relevant and actionable, aiding psychiatrists in offering effective and compassionate care.

Page 12

Recently published articles about Schizophrenia/Schizoaffective Disorders

JCP
Economic Burden of Schizophrenia in the US
Original Research

October 10, 2022

Schizophrenia is associated with significant economic burden, not only for patients but also for families, other caregivers, and the wider society. This study analyzed recent data and literature to...
, , , et al
JCP
Sublingual Dexmedetomidine for Agitation in Schizophrenia
Original Research

October 3, 2022

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or schizoaffective disorder.
, , , et al
JCP
Obsessive-Compulsive Symptoms in Individuals With Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder
Original Research

September 28, 2022

Prevalence and correlates of obsessive-compulsive symptoms and OCD were identified from the case records of over 22,500 patients with schizophrenia, schizoaffective disorder, or bipolar disorder.
, , , et al
JCP
Asenapine, Aggression, and Affinity
Letter to the Editor

September 28, 2022

Dr El-Mallakh comments on a recent study by Citrome et al and discusses his group’s research on antiaggression effects of clozapine.
JCP
Antipsychotic Augmentation With N-Acetylcysteine in Schizophrenia
Clinical and Practical Psychopharmacology

September 26, 2022

Dr Andrade discusses whether or not recent findings support the use of NAC as antipsychotic augmentation in schizophrenia.
PCC
Schizophrenia-Like Psychosis With Recent Syphilis Diagnosis
Case Report

September 22, 2022

Here, read a about a patient who experienced psychiatric symptoms after a recent diagnosis of syphilis.
, ,
JCP
LAI Antipsychotics in Schizophrenia: Long-term Outcomes of Early Use
Insights

September 21, 2022

Using data from the Taiwan National Health Insurance Research Database, Cheng-Yi Huang, MD, explains how he and Su-Chen Fang, PhD, and Yu-Hsuan Joni Shao, PhD, compared long-term effectiveness of...
PCC
Societal Outcomes in US Veterans with Schizophrenia Relapse
Original Research

September 13, 2022

This study evaluated societal outcomes including unemployment and homelessness among US veterans with schizophrenia with a history of relapse.
, , , et al
JCP
Parental Mental Illness and Child Injury Risk
Original Research

September 12, 2022

Childhood injury is associated with parental serious mental illness (SMI). This study investigated whether the associations between parental SMI and child injury vary according to which parent had an...
, , , et al
JCP
Reasons for Switching Antipsychotic Treatments
Original Research

September 5, 2022

Based on prescription records and prescriber notes, almost half of antipsychotic switches were due to side effects, and women were especially likely to be switched due to intolerability or...
, , , et al
PCC
Misdiagnosis of Noah Syndrome
Case Report

September 1, 2022

This patient presented with Noah syndrome, secondary to mental retardation complicated by organic psychosis, misdiagnosed as schizophrenia for 25 years.
PCC
TMS for Schizophrenia Management
Systematic Review

August 25, 2022

In this review, the authors analyze all current literature related to different transcranial magnetic stimulation modalities in the management of schizophrenia symptoms.
, ,

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe